Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-12-07
1993-03-09
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548483, 548450, 514411, A61K 3140, C07D20904, C07D20956
Patent
active
051927926
ABSTRACT:
A method of treatment of central nervous system disorders with compounds having the formula ##STR1## and isomers thereof wherein R.sup.1, R.sup.2, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 and as defined in the specification; as well as pharmaceutical compositions thereof.
REFERENCES:
CA 78:124421k Antiviral Substances, Carbamoyloximine derivatives of isatin and its heterocyclic analogs, Giannella et al. 1973.
Wiss Z, Ernst-Moritz-Arndt, University of Greifswald, Math.-nat.wiss. Reihe 35, 39-44, (1986) 4.
Pharmazie 39, H. 10, 713 (1984), Fisher et al.
Pharmazie 37, H. 12, 858-861 (1982), Fischer et al.
Neuroscience Letters 107, 327-330 (1989), Clow et al.
Khim.-Farm.zh. 23(11), 1349-2352 (1989).
Daignault Ronald A.
Lee Mary C.
McKane Joseph K.
Warner-Lambert & Company
LandOfFree
Isatine derivatives, and their method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isatine derivatives, and their method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isatine derivatives, and their method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-211863